| 2026-03-27 |
股东大会：
将于2026-05-07召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-elect each of the 12 Director nominees as described in this Proxy Statement.
2.To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers (‘NEOs’) for 2025 as disclosed in this Proxy Statement (‘Say-on-Pay’).
3.By separate resolutions: (a) to ratify, in a non-binding vote, the appointment of Deloitte & Touche LLP (‘Deloitte U.S.’) as the Company’s independent registered public accounting firm for fiscal year 2026; (b) to authorize, in a binding vote, the Audit Committee to fix the compensation of Deloitte U.S., Deloitte Ireland LLP (‘Deloitte Ireland’), the member firms of Deloitte Touche Tohmatsu Limited and their respective affiliates (together, ‘Deloitte’).
4.To renew the annual authority of the Board of Directors of the Company to issue shares.
5.To renew the annual authority of the Board of Directors of the Company to issue shares for cash without first offering shares to existing shareholders.
6.To renew the annual authority of the Board of Directors of the Company to make market repurchases and overseas market repurchases of Ordinary Shares of the Company.
7.To renew the annual authority to re-issue treasury shares and determine the price range at which the Company can re-issue such shares that it holds as treasury shares.
8.To approve the Schemes of Arrangement to cancel the Preference Shares and the granting of authority to the Board to take all such actions as it considers necessary or appropriate to give effect to the Schemes of Arrangement.
9.To approve the proposed cancellation of the Preference Shares by way of reduction of capital.
10.To approve the variation to the Company’s authorized share capital by the removal of any cancelled Preference Shares in connection with the proposed Preference Share Cancellations.
11.Approval of certain amendments to the Company’s Articles in connection with the proposed Preference Share Cancellations.
12.Approval of an Amendment to the Company’s Articles to Delete the Qualification Shareholding Requirement for Directors Set Forth Therein.
|
| 2026-03-27 |
股东大会：
将于2026-05-07召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-elect each of the 12 Director nominees as described in this Proxy Statement.
2.To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers (‘NEOs’) for 2025 as disclosed in this Proxy Statement (‘Say-on-Pay’).
3.By separate resolutions: (a) to ratify, in a non-binding vote, the appointment of Deloitte & Touche LLP (‘Deloitte U.S.’) as the Company’s independent registered public accounting firm for fiscal year 2026; (b) to authorize, in a binding vote, the Audit Committee to fix the compensation of Deloitte U.S., Deloitte Ireland LLP (‘Deloitte Ireland’), the member firms of Deloitte Touche Tohmatsu Limited and their respective affiliates (together, ‘Deloitte’).
4.To renew the annual authority of the Board of Directors of the Company to issue shares.
5.To renew the annual authority of the Board of Directors of the Company to issue shares for cash without first offering shares to existing shareholders.
6.To renew the annual authority of the Board of Directors of the Company to make market repurchases and overseas market repurchases of Ordinary Shares of the Company.
7.To renew the annual authority to re-issue treasury shares and determine the price range at which the Company can re-issue such shares that it holds as treasury shares.
8.To approve the Schemes of Arrangement to cancel the Preference Shares and the granting of authority to the Board to take all such actions as it considers necessary or appropriate to give effect to the Schemes of Arrangement.
9.To approve the proposed cancellation of the Preference Shares by way of reduction of capital.
10.To approve the variation to the Company’s authorized share capital by the removal of any cancelled Preference Shares in connection with the proposed Preference Share Cancellations.
11.Approval of certain amendments to the Company’s Articles in connection with the proposed Preference Share Cancellations.
12.Approval of an Amendment to the Company’s Articles to Delete the Qualification Shareholding Requirement for Directors Set Forth Therein.
|
| 2026-03-27 |
详情>>
股本变动：
变动后总股本66939.98万股
|
| 2026-03-12 |
详情>>
内部人交易：
Talbot Siobhan股份增加2000.00股
|
| 2026-02-18 |
详情>>
业绩披露：
2025年年报每股收益5.54美元,归母净利润37.53亿美元,同比去年增长7.47%
|
| 2026-02-18 |
财报披露：
美东时间 2026-02-18 盘后发布财报
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益4.02美元,归母净利润27.28亿美元,同比去年增长-2.19%
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益1.79美元,归母净利润12.25亿美元,同比去年增长-13.31%
|
| 2025-05-05 |
详情>>
业绩披露：
2025年一季报每股收益-0.15美元,归母净利润-9400万美元,同比去年增长-181.03%
|
| 2025-03-28 |
股东大会：
将于2025-05-08召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-elect each of the 12 Director nominees as described in this Notice of Meeting and Proxy Statement.
2.To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers (“NEOs”) for 2024 (“Say-on-Pay”).
3.To approve, on an advisory basis, the frequency of future “Say-on-Pay” votes.
4.To approve the CRH plc Equity Incentive Plan
5.By separate resolutions: (a) to ratify, in a non-binding vote, the appointment of Deloitte & Touche LLP (“Deloitte U.S.”) as the Company’s independent registered public accounting firm for fiscal 2025; (b) to authorize, in a binding vote, the Board of Directors to fix the compensation of Deloitte U.S., Deloitte Ireland LLP (“Deloitte Ireland”) and other Deloitte affiliates (together with Deloitte U.S. and Deloitte Ireland, “Deloitte”).
6.To renew the annual authority of the Board of Directors of the Company to issue shares.
7.To renew the annual authority of the Board of Directors of the Company to issue shares for cash without first offering shares to existing shareholders.
8.To renew the annual authority of the Board of Directors of the Company to make market purchases and overseas market purchases of ordinary shares of the Company.
9.To determine the price range at which the Company can re-issue shares that it holds as treasury shares.
10.To amend the Company’s Articles to clarify the advance notice requirements for Director nominations and other shareholder proposals.
11.By separate resolutions, to amend the Company’s Articles to: (a) provide for a plurality voting standard in the event of contested Director elections; (b) grant the Board sole authority to determine its size and to ensure re-election of at least the minimum number of Directors required.
12.To amend the Company’s Articles to provide the Board with the ability to determine the fees payable to the non-management Directors and make certain administrative amendments.
|
| 2025-03-28 |
股东大会：
将于2025-05-08召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-elect each of the 12 Director nominees as described in this Notice of Meeting and Proxy Statement.
2.To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers (“NEOs”) for 2024 (“Say-on-Pay”).
3.To approve, on an advisory basis, the frequency of future “Say-on-Pay” votes.
4.To approve the CRH plc Equity Incentive Plan
5.By separate resolutions: (a) to ratify, in a non-binding vote, the appointment of Deloitte & Touche LLP (“Deloitte U.S.”) as the Company’s independent registered public accounting firm for fiscal 2025; (b) to authorize, in a binding vote, the Board of Directors to fix the compensation of Deloitte U.S., Deloitte Ireland LLP (“Deloitte Ireland”) and other Deloitte affiliates (together with Deloitte U.S. and Deloitte Ireland, “Deloitte”).
6.To renew the annual authority of the Board of Directors of the Company to issue shares.
7.To renew the annual authority of the Board of Directors of the Company to issue shares for cash without first offering shares to existing shareholders.
8.To renew the annual authority of the Board of Directors of the Company to make market purchases and overseas market purchases of ordinary shares of the Company.
9.To determine the price range at which the Company can re-issue shares that it holds as treasury shares.
10.To amend the Company’s Articles to clarify the advance notice requirements for Director nominations and other shareholder proposals.
11.By separate resolutions, to amend the Company’s Articles to: (a) provide for a plurality voting standard in the event of contested Director elections; (b) grant the Board sole authority to determine its size and to ensure re-election of at least the minimum number of Directors required.
12.To amend the Company’s Articles to provide the Board with the ability to determine the fees payable to the non-management Directors and make certain administrative amendments.
|
| 2025-02-26 |
详情>>
业绩披露：
2024年年报每股收益5.06美元,归母净利润34.92亿美元,同比去年增长9.88%
|
| 2025-02-26 |
详情>>
业绩披露：
2022年年报每股收益5.15美元,归母净利润38.62亿美元,同比去年增长46.84%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益4.03美元,归母净利润27.89亿美元,同比去年增长12.60%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益2.05美元,归母净利润14.13亿美元,同比去年增长20.98%
|
| 2024-05-10 |
详情>>
业绩披露：
2024年一季报每股收益0.16美元,归母净利润1.16亿美元,同比去年增长514.29%
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益4.36美元,归母净利润31.78亿美元,同比去年增长-17.71%
|
| 2022-03-11 |
股东大会：
将于2022-04-28召开股东大会
|
| 2022-03-11 |
股东大会：
将于2022-04-28召开股东大会
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-24 |
股东大会：
将于2021-04-29召开股东大会
|
| 2021-03-24 |
股东大会：
将于2021-04-29召开股东大会
|
| 2021-01-15 |
股东大会：
将于2021-02-09召开股东大会
会议内容 ▼▲
- 1.To consider, and if deemed appropriate, approve certain resolutions required to facilitate the migration of the Company's shares currently held electronically in the UK-based CREST settlement system to the Belgian-based Euroclear Bank SA/NV system (the "Migration").
|
| 2021-01-15 |
股东大会：
将于2021-02-09召开股东大会
会议内容 ▼▲
- 1.To consider, and if deemed appropriate, approve certain resolutions required to facilitate the migration of the Company's shares currently held electronically in the UK-based CREST settlement system to the Belgian-based Euroclear Bank SA/NV system (the "Migration").
|
| 2020-03-06 |
股东大会：
将于2020-04-23召开股东大会
|
| 2020-03-06 |
股东大会：
将于2020-04-23召开股东大会
|
| 2019-08-26 |
除权日：
美东时间 2019-09-05 每股派息0.18美元
|
| 2019-03-08 |
股东大会：
将于2019-04-25召开股东大会
|
| 2019-03-08 |
股东大会：
将于2019-04-25召开股东大会
|
| 2019-03-04 |
除权日：
美东时间 2019-03-14 每股派息0.47美元
|
| 2018-05-07 |
除权日：
美东时间 2018-03-09 每股派息0.47美元
|
| 2017-08-24 |
除权日：
美东时间 2017-09-07 每股派息0.22美元
|
| 2017-03-03 |
除权日：
美东时间 2017-03-09 每股派息0.49美元
|
| 2016-11-07 |
除权日：
美东时间 2016-09-07 每股派息0.21美元
|
| 2016-05-10 |
除权日：
美东时间 2016-03-10 每股派息0.50美元
|
| 2015-08-28 |
除权日：
美东时间 2015-09-09 每股派息0.21美元
|
| 2015-02-27 |
除权日：
美东时间 2015-03-05 每股派息0.49美元
|
| 2015-01-22 |
复牌提示：
2015-01-22 10:48:45 停牌，复牌日期 2015-01-22 11:57:18
|
| 2014-08-19 |
除权日：
美东时间 2014-08-27 每股派息0.25美元
|
| 2014-02-25 |
除权日：
美东时间 2014-03-05 每股派息0.60美元
|
| 2013-08-20 |
除权日：
美东时间 2013-08-28 每股派息0.25美元
|
| 2013-02-26 |
除权日：
美东时间 2013-03-06 每股派息0.57美元
|
| 2012-08-14 |
除权日：
美东时间 2012-08-22 每股派息0.23美元
|
| 2012-02-28 |
除权日：
美东时间 2012-03-07 每股派息0.59美元
|
| 2011-08-16 |
除权日：
美东时间 2011-08-24 每股派息0.27美元
|
| 2011-03-01 |
除权日：
美东时间 2011-03-09 每股派息0.61美元
|
| 2010-08-24 |
除权日：
美东时间 2010-09-01 每股派息0.24美元
|